Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902)

Gastric Cancer 2026

View at publisher
Authors: Shunji Endo, Ryo Tanaka, Toshifumi Yamaguchi, Hiromichi Miyagaki, Junji Kawada, Takeshi Omori, Naoki Takahashi, Toru Masuzawa, Haruna FURUKAWA, Yuya Sato, Atsushi Takeno, Naoki Shinno
+7 more Ryohei Kawabata, Shinsuke Katsuyama, Shigeyoshi Higashi, Yukinori Kurokawa, Toshimasa Tsujinaka, Toshio Shimokawa, Taroh Satoh
DOI: 10.1007/s10120-025-01705-8
Cited by: 1
References: 17

Fields of Study & Subjects

Gastric Cancer Management and Outcomes Helicobacter pylori-related gastroenterology studies Esophageal Cancer Research and Treatment

Publication details

Journal / source
Gastric Cancer
Publisher
Springer Science and Business Media LLC
Volume
29
Issue
2
Pages
387–397
Publication date
21 January 2026
Language
EN